Neuronetics, Inc. (STIM) Stock

Healthcare · Medical Devices · Member of Other US Stocks

Neuronetics, Inc. (STIM) closed at USD 1.88 on 2026-10-14, a change of -39.2 % over the past year, with a market capitalization of USD 148.58M.

Neuronetics, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Neuronetics, Inc. key figures

Previous close

USD 1.88 (2026-10-14)

1-year change

-39.2 %

Market cap

USD 148.58M

Enterprise value

USD 219.7M

P/E ratio (trailing)

-4.76

P/E ratio (forward)

-5.74

EPS (trailing)

-0.41

EPS (forward)

-0.34

PEG ratio

n/a

Price to book

8.33

Revenue growth

9.1 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

5.64

Employees

658

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Neuronetics, Inc.

Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. has a strategic collaboration with ANT Neuro to expand the capabilities of the NeuroStar advanced therapy system with advanced image-guided navigation technology. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Neuronetics, Inc. and compare it with other stocks.